
NEW YORK, Dec. 24 (UPI) -- Flaws in a heart defibrillator were known by manufacturer Guidant, but were viewed as acceptable within a statistical realm, the New York Times reports.
The Indianapolis-based company filed papers in a Texas court indicating officials were aware in 2002 that the consequences of the defibrillator's electrical failure were rare, but could be "life threatening." Despite that assessment, Guidant kept selling potentially flawed devices and did not notify doctors about the defect until last spring, when the problem was about to be made public by the Times, the newspaper said.
At least seven people have died because of the flaw, and Guidant has since recalled 80,000 implantable defibrillators in June. In September, Guidant recalled 380,000 pacemakers.
A chart on the document submitted to the court shows the company's acceptable failure rate was about 15 devices a year, a rate of slightly more than one a month.
"For Guidant, these people are numbers," said Dr. William Maisel, chairman of the Food and Drug Administration advisory committee that reviews heart devices. "Their descriptions are full of numbers. But for me, these patients are people."
|
|
|
|
|
|
| Additional Business News Stories | |
CANBERRA, Australia, May 23 (UPI) --
Australia has passed legislation establishing the $10 billion Clean Energy Finance Corp. to provide grants and government investment to green projects.
|
AVONDALE, La., May 23 (UPI) --
The seventh amphibious transport dock being built by Huntington Ingalls Industries for the U.S. Navy has completed builder sea trials.
|
The housing inventory rose slightly in April, which is unusual in the middle of the spring sales season. The uptick may be the result of rising seller confidence and it should ease concerns that the super tight inventory levels of the last six months...
|
What if Europe turned out to be the new Japan?
|
| Stories | Photos | People | Comments |
View Caption